FDA OKs Indena's France facility

FDA OKs Indena's France facility

Passed inspection confirms that the company meets new Food Safety Modernization Act requirements.

Indena announces that its production site in Tours, France, successfully passed the U.S. FDA inspection, with no FDA-483 issued, as per EIR (Establishment Inspection Report) received from the Center for Food Safety and Applied Nutrition. This confirms that the company meets the new requirements mandated by the FDA Food Safety Modernization Act. The inspection involved the entire organization and focused on manufacturing operations, HACCP, sanification, cleaning, recall, complaint and training program and procedures.

“We are pleased with the successful outcome of the FDA inspection,” said François Mairel, Indena Tours plant director. “The audit covered the manufacturing of important products we sell to our U.S. customer base, such as grape seed, olive polyphenolic and ginkgo biloba extracts, and further confirms our commitment to giving our customers the highest standards of quality.”

Indena Tours previously obtained the following certifications: GMP Certificate from the French Health Ministry, ANSM, HACCP, ISO 14001, kosher, halal.


Hide comments


  • Allowed HTML tags: <em> <strong> <blockquote> <br> <p>

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.